Which statement best reflects the Marketing Experience section?

• A. Countries where IP has not been marketed or approved
• B. The combination of countries marketed or approved and those not approved
• C. Only the pricing data in different markets
• D. The regulatory submission timelines

Answer: (B)

Marketing Experience is about showing where a product has actually been marketed or approved and where it has not. This balance gives a complete picture of the product’s regulatory and market footprint, which informs how data from different regions may be interpreted and how safety and efficacy experiences generalize across markets. The best statement reflects both sides: countries where the product is marketed or approved and those where it is not approved. That combination captures the full geographic and regulatory context.

If you only describe non-marketed countries, you miss where approvals exist and the overall market exposure. If you focus on pricing data, you’re looking at economic information, not market authorization status. If you discuss regulatory submission timelines, you’re addressing the process rather than the actual market presence.